About Exscientia plc - EXAI
Exscientia plc is a pharmaceutical company that utilizes artificial intelligence to design and discover new drugs, aiming to streamline and accelerate the drug development process. It collaborates with various partners from the biotechnology and pharmaceutical industries to work on a diverse range of therapeutic areas.
What are Exscientia plc's core values and mission statement?
Exscientia plc's core values revolve around innovation, collaboration, and the application of artificial intelligence to accelerate drug discovery and design. Their mission is to discover and design the best possible medicines in the fastest and most efficient way.
Who founded Exscientia plc and when?
Exscientia plc was founded by Andrew Hopkins in 2012.
Who leads Exscientia plc?
As of my last update, the CEO of Exscientia plc is Professor Andrew Hopkins.
Where is Exscientia plc located, and what is its base country?
Exscientia plc is headquartered in Oxford, UK, and its base country is the United Kingdom.
On which exchanges is Exscientia plc traded?
Exscientia plc is traded on the NASDAQ stock exchange under the ticker symbol EXAI.
Exscientia plc (EXAI) Price Live Data
The live price of Exscientia plc (EXAI) is $6.16, with a trading volume of 122,834 in the last 24 hours. Wrapstocks updates the EXAI price in real-time. Exscientia plc is up 0.66% in the last 24 hours. The company has a live market cap of $769,630,400.00 and a supply of 124,940,000 EXAI stocks.
Exscientia plc (EXAI) is traded on NASDAQ Stock Exchange, and currently, the market is open; trading will be paused in 4 hours and 54 minutes.